Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 871 AL 885

Sleep Quality and Health-Related Quality of Life in Older People With Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer Disease

Leng M, Yin H, Zhang P, Jia Y, Hu M, Li G, Wang C, Chen L.

J Nerv Ment Dis. 2020 May;208(5):387-396. doi: 10.1097/NMD.0000000000001137.

Background of the neuropathological site in neurocognitive decline in elderly schizophrenic patients

Hirano M, Iritani S, Sekiguchi H, Torii Y, Habuchi C, Fujishiro H, Ozaki N, Yoshida M, Fujita K.

Psychogeriatrics. 2020 Jul;20(4):522-527. doi: 10.1111/psyg.12522. Epub 2020 Jan 29.

Serial position effects on list learning tasks in mild cognitive impairment and Alzheimer's disease

Weitzner DS, Calamia M.

Neuropsychology. 2020 May;34(4):467-478. doi: 10.1037/neu0000620. Epub 2020 Jan 30.

Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kishi T, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Apr;53(3):109-114. doi: 10.1055/a-1076-8228. Epub 2020 Jan 30.

Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease

Levit A, Hachinski V, Whitehead SN.

Geroscience. 2020 Apr;42(2):445-465. doi: 10.1007/s11357-020-00164-6. Epub 2020 Jan 30.

Association of Vitamin D Levels with Incident All-Cause Dementia in Longitudinal Observational Studies: A Systematic Review and Meta-analysis

Kalra A, Teixeira AL, Diniz BS.

J Prev Alzheimers Dis. 2020;7(1):14-20. doi: 10.14283/jpad.2019.44.

Health Literacy in Individuals at Risk for Alzheimer's Dementia: A Systematic Review

Rostamzadeh A, Stapels J, Genske A, Haidl T, Jünger S, Seves M, Woopen C, Jessen F.

J Prev Alzheimers Dis. 2020;7(1):47-55. doi: 10.14283/jpad.2019.34.

Influence of Western diet and APOE genotype on Alzheimer's disease risk

Sullivan PM.

Neurobiol Dis. 2020 May;138:104790. doi: 10.1016/j.nbd.2020.104790. Epub 2020 Feb 4.

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, Huey ED.

BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.

An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease

Hashweh NN, Bartochowski Z, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2020 Apr;21(6):619-627. doi: 10.1080/14656566.2020.1719066. Epub 2020 Feb 8.

Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting

Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF.

Cells. 2020 Feb 7;9(2):383. doi: 10.3390/cells9020383.

Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer's disease

Kang S, Moser VA, Svendsen CN, Goodridge HS.

Commun Biol. 2020 Feb 13;3(1):69. doi: 10.1038/s42003-020-0797-4.

The Interactions Between Alzheimer's Disease and Major Depression: Role of Ca(2+) Channel Blockers and Ca(2+)/cAMP Signalling

Bergantin LB.

Curr Drug Res Rev. 2020;12(2):97-102. doi: 10.2174/2589977512666200217093356.

Delaying memory decline: different options and emerging solutions

Schneider F, Horowitz A, Lesch KP, Dandekar T.

Transl Psychiatry. 2020 Jan 21;10(1):13. doi: 10.1038/s41398-020-0697-x.

Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change

Teimouri E, Rainey-Smith SR, Bharadwaj P, Verdile G, Martins RN.

J Alzheimers Dis. 2020;74(3):713-733. doi: 10.3233/JAD-191033.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias